Targeted analysis of glycerophospholipids and mono-, di-or tri-acylglycerides in liver cancer - Archive ouverte HAL Accéder directement au contenu
Chapitre D'ouvrage Année : 2024

Targeted analysis of glycerophospholipids and mono-, di-or tri-acylglycerides in liver cancer

Résumé

The metabolic rearrangements of hepatic metabolism associated with liver cancer are still incompletely understood. There is an ongoing need to identify novel and more efficient diagnostic biomarkers and therapeutic targets based on the metabolic mechanisms of these diseases. In comparison to traditional diagnostic biomarkers, metabolomics is a comprehensive technique for discovering chemical signatures for liver cancer screening, prediction, and earlier diagnosis. Lipids are a large and diverse group of complex biomolecules that are at the heart of liver physiology and play an important role in the development and progression of cancer. In this chapter, we described two detailed protocols for targeted lipids analysis: glycerophospholipids and mono, di, tri-acylglycerides, both by Flow Injection Analysis (FIA) HPLC coupled to a SelexIon/QTRAP 6500+ system. These approaches provide a targeted lipidomic metabolomic signature of dissimilar metabolic disorders affecting liver cancers.
Fichier principal
Vignette du fichier
PDF_Chapter14.pdf (1.32 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04596723 , version 1 (31-05-2024)

Identifiants

Citer

Hui Chen, Sylvère Durand, Mélanie Bourgin, Flavia Lambertucci, Omar Motiño, et al.. Targeted analysis of glycerophospholipids and mono-, di-or tri-acylglycerides in liver cancer. Liver Carcinogenesis, 2769, Springer US, pp.189-198, 2024, Methods in Molecular Biology, ⟨10.1007/978-1-0716-3694-7_14⟩. ⟨hal-04596723⟩
3 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More